An estimated 500,000 people cross into Mexico every year. The majority making up this massive forced migration flow originate from El Salvador, Honduras, and Guatemala, known as the Northern Triangle of Central America (NTCA), one of the most violent regions in the world today.

FEBRUARY 27, 2017—Thousands of people trying to flee Eritrea are suffering from inhumane, violent, and deadly treatment as the European Union increasingly collaborates with the governments of Eritrea, Libya, Sudan, and Ethiopia to stop them from reaching European shores, according to a new report by the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF).

Violence erupted between internally displaced persons (IDPs) of different ethnic groups in a protection of civilians (PoC) site in Malakal, South Sudan, on February 17, 2016, and continued until the next afternoon. There are strong indications that external military forces were also involved in the fighting.

Globally, the years 2000 to 2015 saw the scaling-up of access to antiretroviral therapy (ART), with a 35 percent decrease in AIDS-related deaths since 2005. A record number of almost 16 million people living with HIV (PLHIV) have been initiated on ART as of mid-2015, three in four of whom live in sub-Saharan Africa, where the needs are most acute. Civil society and public health services alike have rallied to bring new evidence-based treatments and best practices to PLHIV.

The world currently faces its largest global displacement crisis since World War II, with approximately 60 million people currently displaced due to conflict, persecution, and untenable conditions in their home countries. While foreseeable, Europe is still reeling in shock from the sheer numbers of refugees and migrants—approximately one million—who crossed its borders in 2015.

The 2015 Out of Step report presents the results of a survey of 24 countries conducted by Stop TB Partnership and MSF. Building on the first edition of Out of Step published in 2014, this year’s survey tracked of the latest tuberculosis policies, guidelines, and tools across five areas: diagnosis and drug resistance testing; drug-sensitive TB (DS-TB) treatment regimens; MDR-TB treatment regimens; models of care; and regulatory frameworks.